Their B.Sc. Nuclear Medicine Technology program offers a comprehensive curriculum that equips students with both theoretical knowledge and practical skills in this specialised field. By delving into topics like radiopharmaceuticals, radiation safety, and imaging techniques, the program prepares graduates to play a crucial role in nuclear medicine departments of hospitals and clinics. Visit here:- https://sahs.jainuniversity.ac.in/programs/bsc-nuclear-medicine-technology-colleges-in-bangalore.php

In 2021, the market for Radiopharmaceuticals worldwide was worth $ 4.90 billion US dollars. AMR Group projects that the market will reach US$ 13.3 billion by 2031, growing at a CAGR of 11.2 percent between 2022 and 2031. Radiopharmaceuticals, also known as radiolabeled compounds or radiotracers, are drugs that contain a radioactive isotope. These drugs are used in nuclear medicine imaging to visualize the structure and function of organs and tissues inside the body. Radiopharmaceuticals are usually administered intravenously, inhaled, or ingested, and they accumulate in specific organs or tissues, emitting radiation that is detected by a gamma camera or PET scanner. Radiopharmaceuticals are often used to diagnose and treat various medical conditions, including cancer, heart disease, and neurological disorders. They are also used to monitor the effectiveness of treatments and to identify the presence of disease before symptoms develop. There are different types of radiopharmaceuticals, each with its unique properties and applications. For example, some radiopharmaceuticals emit gamma radiation, while others emit positrons, which are used in PET imaging. The choice of radiopharmaceutical used depends on the specific medical condition being diagnosed or treated, as well as the imaging modality used. Get Details: https://analyticsmarketresearch.com/reports/radiopharmaceuticals-market/52153/

https://www.databridgemarketresearch.com/reports/global-nuclear-medicine-equipment-market